{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:13:04Z","timestamp":1793326384708,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The mechanisms that lead to disease onset and propagation in patients with chronic rhinosinusitis (CRS) are not fully elucidated. Maresins (MaR) are a family of essential fatty acid-derived lipid mediators that play a central role in the regulation of inflammation with several studies demonstrating that these mediators display protective activities in airway inflammation. Therefore, in the present studies we evaluated whether concentrations of these mediators were altered in both peripheral blood and nasal secretions from CRS patients. Herein, we focused on patients with CRS that also develop nasal polyps (CRSwNP), given that therapeutic options for the treatment of these patients are limited. Thereby, insights into disease mechanisms in these patients may help design more effective treatments. For this purpose, we compared maresin concentrations from CRSwNP patients with those found in healthy volunteers or patients with an upper respiratory tract infection (URTI), as a self-resolving inflammatory condition. Using liquid chromatography tandem mass spectrometry, we found that MaR concentrations were significantly decreased in plasma from patients with CRSwNP when compared to healthy volunteers. MaR concentrations were observed to be significantly upregulated in nasal secretions from patients with CRSwNP when compared with both healthy volunteers and URTI subjects. Concentration of these mediators in both plasma and nasal secretions from CRSwNP patients were positively correlated with quality-of-life scores in these patients. Assessment of the concentrations of other pro-resolving and pro-inflammatory lipid mediators (LM) demonstrated that there was a general shift in LM levels in both plasma and nasal secretions from CRSwNP when compared with healthy volunteers and URTI subjects. Of note, incubation of peripheral blood cells from CRSwNP patients with MaR1 downregulated the expression of activation markers on peripheral blood phagocytes, including CD41 and CD62P, markers of platelet-leukocyte heterotypic aggregates. Together these findings demonstrate that both local and systemic LM concentrations, in particularly those of the MaR family, become altered in patients with CRSwNP. They also suggest that therapeutics designed around MaR1 may be useful in regulating the activation of phagocytes in patients with CRSwNP thereby potentially also limiting the local inflammatory response in these patients.<\/jats:p>","DOI":"10.3389\/fimmu.2021.733019","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:24:01Z","timestamp":1630704241000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Issa","family":"Beegun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duco S.","family":"Koenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Alusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesmond","family":"Dalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/0194599818774006","article-title":"Prevalence of Potential Adult Chronic Rhinosinusitis Symptoms in the United States","volume":"159","author":"Bhattacharyya","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S290424","article-title":"Burden of Disease in Chronic Rhinosinusitis With Nasal Polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/28.4.717","article-title":"Prevalence of Asthma, Aspirin Intolerance, Nasal Polyposis and Chronic Obstructive Pulmonary Disease in a Population-Based Study","volume":"28","author":"Hedman","year":"1999","journal-title":"Int J Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00688.x","article-title":"Prevalence of Nasal Polyposis in France: A Cross-Sectional, Case-Control Study","volume":"60","author":"Klossek","year":"2005","journal-title":"Allergy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical Characteristics of Patients With Chronic Rhinosinusitis Without Nasal Polyps in an Academic Setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13012","article-title":"Current Use of Baseline Medical Treatment in Chronic Rhinosinusitis: Data From the National Chronic Rhinosinusitis Epidemiology Study (CRES)","volume":"43","author":"Philpott","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70152-4","article-title":"The Health Impact of Chronic Sinusitis in Patients Seeking Otolaryngologic Care","volume":"113","author":"Gliklich","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of Chronic Rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e022644","DOI":"10.1136\/bmjopen-2018-022644","article-title":"Chronic Rhinosinusitis: A Qualitative Study of Patient Views and Experiences of Current Management in Primary and Secondary Care","volume":"9","author":"Vennik","year":"2019","journal-title":"BMJ Open"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2500\/108854193778774065","article-title":"Anaphylaxie Et Idiosyncrasie. 1992 [Anaphylaxis and Idiosyncrasy. 1992]","volume":"14","author":"Widal","year":"1993","journal-title":"Allergy Proc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and Management of NSAID-Exacerbated Respiratory Disease (N-ERD)-A EAACI Position Paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70163-0","article-title":"Nasal Provocation Test With Lysine-Aspirin for Diagnosis of Aspirin-Sensitive Asthma","volume":"101","author":"Milewski","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12110","article-title":"Nasal Lysine Aspirin Challenge in the Diagnosis of Aspirin - Exacerbated Respiratory Disease: Asthma and Rhinitis","volume":"43","author":"Miller","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.07.011","article-title":"Specialized Pro-Resolving Lipid Mediators in Cardiovascular Disease, Diagnosis, and Therapy","volume":"159","author":"Kim","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00252","article-title":"Roles, Actions, and Therapeutic Potential of Specialized Pro-Resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis","volume":"10","author":"Recchiuti","year":"2019","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","article-title":"New Pro-Resolving N-3 Mediators Bridge Resolution of Infectious Inflammation to Tissue Regeneration","volume":"64","author":"Serhan","year":"2018","journal-title":"Mol Aspects Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 Is a Potent Regulator of Leukocytes and Controls Microbial Sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"102218","DOI":"10.1016\/j.plefa.2020.102218","article-title":"Altered Tissue Specialized Pro-Resolving Mediators in Chronic Rhinosinusitis","volume":"164","author":"Vickery","year":"2021","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/s41467-020-19176-z","article-title":"Blood Pro-Resolving Mediators Are Linked With Synovial Pathology and Are Predictive of DMARD Responsiveness in Rheumatoid Arthritis","volume":"11","author":"Gomez","year":"2020","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhino50E2","article-title":"EPOS 2012: European Position Paper on Rhinosinusitis and Nasal Polyps 2012.\u00a0A Summary for Otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4193\/Rhino15.284","article-title":"Using Postoperative SNOT-22 to Help Predict the Probability of Revision Sinus Surgery","volume":"54","author":"Rudmik","year":"2016","journal-title":"Rhinology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.09.016","article-title":"Development and Validation of the Nasal Obstruction Symptom Evaluation (NOSE) Scale","volume":"130","author":"Stewart","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 Measure of Health-Related Quality of Life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: Narrowing the Gap Between Raw Spectra and Functional Insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2012.10.011","article-title":"Utilities for Quantifying Separation in PCA\/PLS-DA Scores Plots","volume":"433","author":"Worley","year":"2013","journal-title":"Anal Biochem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.09.028","article-title":"Cysteinyl Maresins Regulate the Prophlogistic Lung Actions of Cysteinyl Leukotrienes","volume":"145","author":"Levy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2015.01.001","article-title":"Maresin-1 Reduces Airway Inflammation Associated With Acute and Repetitive Exposures to Organic Dust","volume":"166","author":"Nordgren","year":"2015","journal-title":"Transl Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1407123111","article-title":"Maresin 1 Biosynthesis During Platelet-Neutrophil Interactions Is Organ-Protective","volume":"111","author":"Abdulnour","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e022643","DOI":"10.1136\/bmjopen-2018-022643","article-title":"Management Strategies for Chronic Rhinosinusitis: A Qualitative Study of GP and ENT Specialist Views of Current Practice in the UK","volume":"8","author":"Vennik","year":"2018","journal-title":"BMJ Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1017\/S0022215119002639","article-title":"Simulation-Based ENT Induction: Validation of a Novel Mannequin Training Model","volume":"134","author":"Bhalla","year":"2020","journal-title":"J Laryngol Otol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312472","article-title":"Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease","volume":"122","author":"Colas","year":"2018","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007252","article-title":"Platelet Activation and Platelet-Monocyte Aggregate Formation Trigger Tissue Factor Expression in Patients With Severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.733019\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:24:05Z","timestamp":1630704245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.733019\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2021.733019"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.733019","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"article-number":"733019"}}